Identification and Screening of Novel Antimicrobial Peptides from Medicinal Leech via Heterologous Expression in Escherichia coli
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26146903 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Maria Serebrennikova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Moscow Center for Advanced Studies 20, Kulakova Str., Moscow 123592, Russia. Hauptthemen laut MEDLINE: Escherichia coli, Antimicrobial Peptides, Hirudo medicinalis, Antimicrobial Cationic Peptides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
The growing threat of infectious diseases requires novel therapeutics with different mechanisms of action. Antimicrobial peptides (AMPs), which are crucial for innate immunity, are a promising research area. The medicinal leech (Hirudo medicinalis) is a potential source of bioactive AMPs that are vital while interacting with microorganisms. This study aims to investigate the antimicrobial properties of peptides found in the H. medicinalis genome using a novel high-throughput screening method based on the expression of recombinant AMP genes in Escherichia coli. This approach enables the direct detection of AMP activity within cells, skipping the synthesis and purification steps, while allowing the simultaneous analysis of multiple peptides. The application of this method to the first identified candidate AMPs from H. medicinalis resulted in the discovery of three novel peptides: LBrHM1, NrlHM1 and NrlHM2. These peptides, which belong to the lumbricin and macin families, exhibit significant activity against E. coli. Two fragments of the new LBrHM1 homologue were synthesised and studied: a unique N-terminal fragment (residues 1–23) and a fragment (residues 27–55) coinciding with the active site of lumbricin I. Both fragments exhibited antimicrobial activity in a liquid medium against Bacillus subtilis. Notably, the N-terminal fragment lacks homologues among previously described AMPs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Moscow Center for Advanced Studies 20, Kulakova Str., Moscow 123592, Russia.
- Laboratory of Genetic Engineering, Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow 119435, Russia.
ORCID-Profile: Maria Serebrennikova, Ekaterina Grafskaia, Daria Kharlampieva, Ksenia Brovina, Pavel Bobrovsky, Valentin Manuvera
Förderung
- Russian Science Foundation
Zitieren
APA
Serebrennikova, M., Grafskaia, E., Kharlampieva, D., Brovina, K., Bobrovsky, P., Alieva, S., Manuvera, V., & Lazarev, V. (2025). Identification and Screening of Novel Antimicrobial Peptides from Medicinal Leech via Heterologous Expression in Escherichia coli. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26146903
Vancouver
Serebrennikova M, Grafskaia E, Kharlampieva D, Brovina K, Bobrovsky P, Alieva S, et al. Identification and Screening of Novel Antimicrobial Peptides from Medicinal Leech via Heterologous Expression in Escherichia coli. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26146903
BibTeX
@article{Serebrennikova2025,
author = {Serebrennikova, Maria and Grafskaia, Ekaterina and Kharlampieva, Daria and Brovina, Ksenia and Bobrovsky, Pavel and Alieva, Sabina and Manuvera, Valentin and Lazarev, Vassili},
title = {Identification and Screening of Novel Antimicrobial Peptides from Medicinal Leech via Heterologous Expression in Escherichia coli},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26146903}
}
EUVIMED